Zocor vs. Livalo
See how Zocor and Livalo compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Both are once-daily statins that lower LDL cholesterol, but Zocor is available as a low-cost generic while Livalo remains brand-only.
Zocor carries added FDA-approved indications for reducing heart attack, stroke, and death risk in high-risk patients, while Livalo's approved uses focus on cholesterol reduction itself.
Livalo has fewer CYP3A4 drug interactions than Zocor, which is contraindicated with strong CYP3A4 inhibitors.
Zocor vs. Livalo Drug Summary
Zocor
Zocor (simvastatin) is a statin that lowers LDL cholesterol and is also approved to reduce the risk of heart attack, stroke, and death in people at high cardiovascular risk. It is taken as a once-daily oral tablet and has been available as a low-cost generic for years.
Livalo
Livalo (pitavastatin) is a statin that lowers LDL cholesterol, total cholesterol, and triglycerides in adults with high cholesterol or mixed dyslipidemia, and in people with familial hypercholesterolemia. It is taken as a once-daily oral tablet and is only available as a brand-name drug.
Zocor vs. Livalo Side Effects
Zocor
Livalo
Zocor vs. Livalo Dosage
Zocor
Livalo
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | At the start |
| Maximum dose | 80 mg once daily | If needed |
| Dose changes | 3 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | At the start |
| Maximum dose | 4 mg once daily | If needed |
| Dose changes | 2 increases | As tolerated |
Zocor
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | At the start |
| Maximum dose | 80 mg once daily | If needed |
| Dose changes | 3 increases | As tolerated |
Livalo
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | At the start |
| Maximum dose | 4 mg once daily | If needed |
| Dose changes | 2 increases | As tolerated |
Zocor vs. Livalo Indications
Zocor
Zocor is FDA-approved to lower LDL cholesterol in adults with high cholesterol and to treat both heterozygous and homozygous familial hypercholesterolemia. It also carries an approved indication for reducing the risk of heart attack, stroke, and death in people with heart disease or diabetes at high cardiovascular risk.
Lower LDL cholesterol in adults with primary hyperlipidemia
Treat heterozygous familial hypercholesterolemia (ages 10+)
Adjunct therapy for homozygous familial hypercholesterolemia
Reduce risk of heart attack, stroke, and death in high-risk adults
Livalo
Livalo is FDA-approved to lower LDL cholesterol, total cholesterol, and triglycerides in adults with high cholesterol or mixed dyslipidemia, and to lower LDL cholesterol in people with heterozygous familial hypercholesterolemia, including children as young as 8. Unlike Zocor, it does not carry an FDA-approved indication for reducing cardiovascular events.
Lower LDL-C, cholesterol, and triglycerides in hyperlipidemia or mixed dyslipidemia
Reduce LDL-C in adults with heterozygous familial hypercholesterolemia
Reduce LDL-C in children 8+ with heterozygous familial hypercholesterolemia
Off-label: primary prevention of cardiovascular disease
Zocor vs. Livalo Pros and Cons
Zocor
Zocor has the longest track record of any statin on this list, backed by decades of outcomes data and a widely available low-cost generic. Its main tradeoffs are a stricter drug interaction profile and dose-dependent muscle risk at the 80 mg ceiling.
Pros
Available as low-cost generic, typically $75 to $100 per month without insurance
FDA-approved to reduce risk of heart attack, stroke, and death in high-risk patients
Decades of long-term safety data since its 1991 approval
Multiple dose strengths (10-80 mg) allow flexible titration
Cons
Contraindicated with strong CYP3A4 inhibitors, limiting use with certain common drugs
Higher risk of myopathy and rhabdomyolysis at the 80 mg dose
80 mg dose restricted to patients already tolerating it for 12+ months
Not approved for children under 10
Livalo
Livalo offers a cleaner drug interaction profile than many statins because it is minimally metabolized through CYP3A4, and it is approved for children as young as 8. As a brand-only medication, it costs substantially more each month than generic Zocor.
Pros
Minimal CYP3A4 metabolism means fewer drug-drug interactions
No history of an FDA boxed warning for high-dose muscle risk
Approved down to age 8 for heterozygous familial hypercholesterolemia
Bioequivalent alternative (Zypitamag) available if needed
Cons
No generic for brand Livalo; roughly $315 to $410 per month without insurance
Contraindicated with cyclosporine due to sharply increased drug exposure
Not approved for reducing cardiovascular events, only cholesterol reduction
Fewer dose strength options (1-4 mg) than Zocor
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.